Combination therapy with moderate-intensity statins and ezetimibe and risk of incident PCI/CABG in atherosclerotic cardiovascular disease: a propensity-matched cohort studyResearch in context

Summary: Background: Combination therapy with moderate-intensity statins and ezetimibe has demonstrated advantages over high-intensity statin monotherapy for several cardiovascular outcomes. However, its effect on the risk of incident percutaneous coronary intervention (PCI) and coronary artery byp...

Descripció completa

Dades bibliogràfiques

Autors principals:	Haonan He, Junhan Tang, Vincent Ka Chun Yan, Joseph Edgar Blais, Chun-Ka Wong, Mark Tsz Kin Tam, Hei Hang Edmund Yiu, Hung-Fat Tse, Esther Wai Yin Chan
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-06-01
Col·lecció:	The Lancet Regional Health. Western Pacific
Matèries:	Coronary revascularisation Statin Ezetimibe LDL-C reduction
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666606526000994
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!